Stanley Druckenmiller: portfolio of Duquesne Family Office

Stanley Druckenmiller manages his own wealth through the Duquesne Family Office; earlier he ran the macro fund Duquesne Capital.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2013. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2013. Go to the latest filing (Q3 2026)

673.8M USDQ2 2013
Total value of stock positions
673.8M USD
Positions
17
Share of the ten largest
87.9%

The ten largest positions Q2 2013

  1. Google Inc. 29.2%
  2. CBS Corp 14.8%
  3. Delta Air Lines 10.7%
  4. Procter & Gamble 6.5%
  5. US Airways Group Inc. 5.8%
  6. Charter Communications 5.0%
  7. Workday, Inc. 4.8%
  8. Gilead Sciences 4.6%
  9. Verizon 3.5%
  10. Cubist Pharms Inc. 3.0%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 4.5B USD).
Choose a quarter (54 filings)

All positions Q2 2013

There is no filing for the previous quarter – changes cannot be shown for Q2 2013.

Positions Q2 2013 per 13F filing, 17 of 17
Symbol Weight Shares Reported value Change Held since
Google Inc. 29.2% 223,250 196.5M USD – Q2 2013 or earlier 1 quarter
CBS Corp 14.8% 2,044,000 99.9M USD – Q2 2013 or earlier 1 quarter
DAL Delta Air Lines 10.7% 3,861,500 72.2M USD – Q2 2013 or earlier 1 quarter
PG Procter & Gamble 6.5% 566,300 43.6M USD – Q2 2013 or earlier 1 quarter
US Airways Group Inc. 5.8% 2,364,000 38.8M USD – Q2 2013 or earlier 1 quarter
CHTR Charter Communications 5.0% 272,000 33.7M USD – Q2 2013 or earlier 1 quarter
WDAY Workday, Inc. 4.8% 505,500 32.4M USD – Q2 2013 or earlier 1 quarter
GILD Gilead Sciences 4.6% 610,700 31.3M USD – Q2 2013 or earlier 1 quarter
VZ Verizon 3.5% 473,000 23.8M USD – Q2 2013 or earlier 1 quarter
Cubist Pharms Inc. 3.0% 413,000 19.9M USD – Q2 2013 or earlier 1 quarter
BIIB Biogen 2.9% 91,500 19.7M USD – Q2 2013 or earlier 1 quarter
LYB LyondellBasell 2.1% 218,000 14.4M USD – Q2 2013 or earlier 1 quarter
JNJ Johnson & Johnson 1.6% 129,000 11.1M USD – Q2 2013 or earlier 1 quarter
Select Sector SPDR TR 1.6% 544,700 10.6M USD – Q2 2013 or earlier 1 quarter
BA Boeing 1.5% 99,200 10.2M USD – Q2 2013 or earlier 1 quarter
BSX Boston Scientific 1.4% 1,000,000 9.3M USD – Q2 2013 or earlier 1 quarter
Select Sector SPDR TR 0.9% 204,500 6.3M USD – Q2 2013 or earlier 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Industrials 12.2%
  • Health Care 10.6%
  • Communication Services 8.5%
  • Consumer Staples 6.5%
  • Technology 4.8%
  • Materials 2.1%
  • not in our coverage 55.2%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close